Search results
Results from the WOW.Com Content Network
Vinpocetine does not fully support a benefit in either dementia or stroke. [12] [9] [13] As of 2003, three controlled clinical trials had tested "older adults with memory problems". [14] Vinpocetine has also been studied for the prevention and recovery of acquired hearing loss in a phase II, longitudinal and prospective open clinical study on ...
Vinpocetine is a synthetic derivative of vincamine used for cerebrovascular diseases and as dietary supplement. [4] Vincamine derivatives have been also studied as anti addictive [ 5 ] and antidiabetic [ 6 ] agents.
The symptoms of a mini and major stroke aren't much different, but Dr. Itrat says ones from a TIA will resolve in a short timeframe. In either case, calling for help is critical.
The most frequent presenting signs and symptoms of primary CNS vasculitis were focal neurological deficits (seen in 63% of cases), headaches (51%) and cognitive impairment (41%). [4] Other presenting symptoms include aphasia or other difficulties with speech (35-43%), ataxia , visual field deficits, acute or subacute encephalopathy (which may ...
A transient ischemic attack (TIA) is also called a “mini stroke”. The symptoms can be similar but usually only last a few minutes and resolve within 24 hours. stefanamer/istockphoto. ED.
Other symptoms can include numbness in the face, arm, or leg, particularly if it’s one side of the body, confusion, trouble seeing, trouble walking, and a severe headache with no known cause.
Nicergoline, sold under the brand name Sermion among others, is an ergot derivative used to treat senile dementia and other disorders with vascular origins. Internationally it has been used for frontotemporal dementia as well as early onset in Lewy body dementia and Parkinson's dementia.
A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.